glucagon has been researched along with cgp 20712a in 2 studies
| Studies (glucagon) | Trials (glucagon) | Recent Studies (post-2010) (glucagon) | Studies (cgp 20712a) | Trials (cgp 20712a) | Recent Studies (post-2010) (cgp 20712a) |
|---|---|---|---|---|---|
| 26,039 | 1,498 | 3,054 | 233 | 2 | 25 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hernández, J; Juan-Fita, MJ; Vargas, ML | 1 |
| Chan, O; Dziura, J; Horblitt, A; Sherwin, RS; Szepietowska, B; Zhu, W | 1 |
2 other study(ies) available for glucagon and cgp 20712a
| Article | Year |
|---|---|
The phosphodiesterase 3 inhibitor cilostamide enhances inotropic responses to glucagon but not to dobutamine in rat ventricular myocardium.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenine; Adrenergic beta-Antagonists; Animals; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Dobutamine; Dose-Response Relationship, Drug; Drug Synergism; Exonucleases; Female; Glucagon; Heart Ventricles; Imidazoles; In Vitro Techniques; Male; Myocardial Contraction; Phosphodiesterase I; Phosphodiesterase Inhibitors; Purinergic P1 Receptor Antagonists; Quinolones; Rats; Rats, Sprague-Dawley; Ventricular Function; Xanthines | 2005 |
Modulation of β-adrenergic receptors in the ventromedial hypothalamus influences counterregulatory responses to hypoglycemia.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Antagonists; Animals; Blood Glucose; Epinephrine; Ethanolamines; Formoterol Fumarate; Glucagon; Glucose Clamp Technique; Hypoglycemia; Imidazoles; Insulin; Male; Norepinephrine; Propanolamines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Ventromedial Hypothalamic Nucleus | 2011 |